The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

@article{Wormser2006TheCA,
  title={The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.},
  author={Gary P. Wormser and Raymond J Dattwyler and Eugene D Shapiro and John J. Halperin and Allen C. Steere and Mark S. Klempner and Peter J. Krause and Johan S. Bakken and Franc Strle and Gerold Stanek and Linda K Bockenstedt and Durland Fish and J Stephen Dumler and Robert B. Nadelman},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2006},
  volume={43 9},
  pages={
          1089-134
        }
}
  • G. WormserR. Dattwyler R. Nadelman
  • Published 1 November 2006
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Evidence-based guidelines for the management of patients with Lyme disease, human granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and babesiosis were prepared by an expert panel of the Infectious Diseases Society of America. These updated guidelines replace the previous treatment guidelines published in 2000 (Clin Infect Dis 2000; 31[Suppl 1]:1-14). The guidelines are intended for use by health care providers who care for patients who either have these infections… 

Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease

Clinical practice guidelines are intended to assist clinicians by presenting evidence-based treatment recommendations, which follow the Grading of Recommendations Assessment, Development and Evaluation system.

Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.

Evidence supports the use of US Food and Drug Administration-approved serologic tests, such as an enzyme immunoassay (EIA), followed by Western blot testing, to diagnose extracutaneous manifestations of Lyme disease.

Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis.

  • P. KrauseP. Auwaerter G. Wormser
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
The target audience for the babesiosis guideline includes primary care physicians and specialists caring for this condition, such as infectious diseases specialists, emergency physicians, intensivists, internists, pediatricians, hematologists, and transfusion medicine specialists.

Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.

  • P. LantosJ. Rumbaugh L. Zemel
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of

Lyme disease: clinical diagnosis and treatment.

Clinicians need to be aware of the signs and symptoms of Lyme disease and knowing the regions where Borrelia infection is endemic in North America is important for recognizing patients at risk and informing the need for treatment.

Update of the Swiss guidelines on post-treatment Lyme disease syndrome.

Growing and unequivocal evidence confirms that prolonged or repeated antibiotic therapy for PTLDS is not beneficial, but potentially harmful and therefore contraindicated.

Lyme Disease Patient Outcomes and Experiences; A Retrospective Cohort Study

It was found that the majority of Lyme disease patients at the clinic responded positively to treatment and a significant decrease in symptoms was observed over time, which may help to guide physicians to provide their patients with the most effective care.

To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis.

  • R. DessauA. V. van Dam F. Strle
  • Medicine
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2018

Diagnosis and treatment of Lyme disease.

The risk factors, clinical presentation, treatment, and prophylaxis for Lyme disease, the most common tick-borne disease in the United States, are detailed, and preventive measures should be emphasized to patients.
...

References

SHOWING 1-10 OF 486 REFERENCES

Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals.

  • A. S. ChapmanJ. Bakken C. Ohl
  • Medicine
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
  • 2006
This report will assist clinicians and other health-care and public health professionals to develop a differential diagnosis that includes and ranks TBRD, understand that the recommendations for doxycycline are the treatment of choice for both adults and children, and understand that early empiric antibiotic therapy can prevent severe morbidity and death.

Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease.

  • P. KrauseK. McKay A. Spielman
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2002
Physicians should consider use of tests designed to diagnose babesiosis and HGE in patients with Lyme disease who experience a prolonged flulike illness that fails to respond to appropriate antiborrelial therapy.

Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin.

  • E. BelongiaK. Reed M. Schriefer
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1999
The clinical spectrum of HGE overlaps that of Lyme disease, and physicians in areas of endemicity should consider both diseases in treating patients with a compatible rash or febrile illness.

Treatment and prevention of Lyme disease, with emphasis on antimicrobial therapy for neuroborreliosis and vaccination.

  • G. Wormser
  • Medicine, Biology
    Seminars in neurology
  • 1997
Available data indicate that a 2-4-week treatment course is adequate for most patients and Ceftriaxone is the most convenient parenteral agent for stage 2 and 3 neuroborreliosis because of its once-daily dosage.

Lyme disease: insights into the use of antimicrobials for prevention and treatment in the context of experience with other spirochetal infections.

  • G. Wormser
  • Medicine, Biology
    The Mount Sinai journal of medicine, New York
  • 1995
There is no convincing evidence for extending treatment of early Lyme disease beyond 14 days, and there is also no evidence that longer therapy is more efficacious for other manifestations of Lyme disease, although this issue deserves further study.

Lyme disease: insights into the use of antimicrobials for prevention and treatment in the context of experience with other spirochetal infections.

There is no convincing evidence for extending treatment of early Lyme disease beyond 14 days, and there is also no evidence that longer therapy is more efficacious for other manifestations of Lyme disease, although this issue deserves further study.

Principles of the diagnosis and antibiotic treatment of Lyme borreliosis.

  • F. Strle
  • Medicine, Biology
    Wiener klinische Wochenschrift
  • 1999
The characteristic sign that permits the diagnosis of Lyme borreliosis is a typical erythema migrans skin lesion, and highly suggestive manifestations are ear lobe lymphocytoma, acrodermatitis chronica atrophicans and Bannwarth's syndrome.

Diagnosis of human granulocytic ehrlichiosis: state of the art.

Human granulocytic ehrlichiosis is an emerging zoonosis caused by Anaplasma phagocytophilum and transmitted through the bite of infected Ixodes scapularis. It is prevalent in the Midwest and

Clinical and laboratory characteristics of human granulocytic ehrlichiosis.

The differential diagnosis for patients who develop an influenzalike illness following a tick bite should include HGE, and microscopic examination of the acute-phase blood smear to detect neutrophilic morulae is currently the quickest and most practical screening method for diagnosing HGE in the upper Midwest.

Laboratory Evaluation in the Diagnosis of Lyme Disease

This background paper provides a quantitative and qualitative evaluation of the predictive value of the laboratory diagnosis of Lyme disease and makes recommendations for the diagnostic workup of patients suspected of having Lyme disease.
...